Interview: Spago Nanomedical – Aiming to improve cancer care
The company recently reached an important milestone with its contrast agent SpagoPix and, if the results are positive, it could enhance cancer care. Spago Nanomedical was founded in 2007 as a subsidiary of Accelerator Nordic. The purpose was to advance an invention from the University of Linköping regarding the use of gadolinium-based nanoparticles as a … Continue reading Interview: Spago Nanomedical – Aiming to improve cancer care
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed